Form 4: Zai Lab Executive Rafael Amado Reports Stock Transactions
SEC Form 4 Filing
Rafael Amado, a Zai Lab executive, reported the acquisition and disposal of American Depositary Shares (ADS) related to the vesting and tax obligations of Restricted Share Units (RSUs).
Summary
- On April 1, 2025, Rafael Amado, President, Head of Global Oncology Research and Development at Zai Lab, acquired 19,523 American Depositary Shares (ADS) upon the vesting of Restricted Share Units (RSUs).
- On April 2, 2025, Mr. Amado disposed of 7,541 ADSs at a price of $35.894 per ADS to cover taxes associated with the vesting of the RSUs.
- Following these transactions, Mr. Amado directly owns 42,816 ADSs.
- Mr. Amado also holds 58,569 Restricted Share Units (RSUs).
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Future Outlook
The RSUs vest in equal annual installments over four years beginning on April 1, 2025, subject to continuous service.
Industry Context
This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the transactions of company insiders.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax-related sales.
Key Dates
| Date | Description |
|---|---|
| 04/01/2025 | Date of earliest transaction; Acquisition of ADSs upon vesting of RSUs; RSUs vest in equal annual installments over four years beginning on this date. |
| 04/02/2025 | Disposal of ADSs to cover taxes. |
| 04/03/2025 | Date of signature. |
Keywords
Zai Lab, Rafael Amado, ADS, American Depositary Shares, RSU, Restricted Share Units, Form 4, Beneficial Ownership, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.